Literature DB >> 2575029

Neuroendocrine response in acute heart failure and the influence of treatment.

M Broqvist1, U Dahlström, B E Karlberg, E Karlsson, T Marklund.   

Abstract

Vasoactive humoral factors were measured in 27 patients before and during the first week of conventional treatment of acute heart failure. On admission, all patients were given frusemide intravenously, followed by oral digoxin and diuretic therapy. Before drug treatment, plasma renin activity and plasma angiotensin II concentrations were within normal ranges in the group of patients without previous diuretic treatment, but were significantly higher in those 16 patients already on diuretic drugs when admitted to hospital. After diuretic treatment, however, even the former group revealed activation of the renin-angiotensin system. Plasma concentrations of catecholamines were increased initially but normalized within 1 day. A majority of the patients initially had very high plasma concentrations of atrial natriuretic peptide (mean 276.9 +/- 39.0 pg ml-1) which decreased but did not normalize during the study period. High plasma levels of arginine vasopressin (mean 56.8 +/- 14.6 pg ml-1) were found, but tended to be reduced during treatment. Thus, patients with acute heart failure displayed increased plasma concentrations of atrial natriuretic peptide, arginine vasopressin and catecholamines, but these vasoactive hormones decreased in parallel to clinical improvement during diuretic therapy. In contrast, the renin-angiotensin system became clearly activated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575029     DOI: 10.1093/oxfordjournals.eurheartj.a059429

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  17 in total

1.  Changes in AVP following aggressive diuretic therapy of severe congestive cardiac failure in elderly patients.

Authors:  E Mulkerrin; M D Penney; K Donovan; D Hampton; J Arnold; D Sykes
Journal:  Postgrad Med J       Date:  1991-12       Impact factor: 2.401

2.  Present treatment options in congestive heart failure.

Authors:  W Remme
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

Review 3.  Neuroendocrine activation after myocardial infarction: causes and consequences.

Authors:  J G Cleland; P J Cowburn; K Morgan
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 4.  Neuroendocrine changes in chronic cardiac failure.

Authors:  D P Nicholls; G N Onuoha; G McDowell; J S Elborn; M S Riley; A M Nugent; I C Steele; C Shaw; K D Buchanan
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

Review 5.  Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment.

Authors:  Y S Tuininga; D J van Veldhuisen; J Brouwer; J Haaksma; H J Crijns; A J Man in't Veld; K I Lie
Journal:  Br Heart J       Date:  1994-12

Review 6.  Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?

Authors:  A Sigurdsson; K Swedberg
Journal:  Br Heart J       Date:  1994-09

Review 7.  Neurohormonal mechanisms and the role of angiotensin-converting enzyme (ACE) inhibitors in heart failure.

Authors:  A J Coats; S Adamopoulos
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

8.  Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates.

Authors:  M Pepi; G C Marenzi; P G Agostoni; E Doria; P Barbier; M Muratori; F Celeste; M D Guazzi
Journal:  Br Heart J       Date:  1993-08

9.  Tumor necrosis factor receptor-associated factor 2 signaling provokes adverse cardiac remodeling in the adult mammalian heart.

Authors:  Vijay G Divakaran; Sarah Evans; Veli K Topkara; Abhinav Diwan; Jana Burchfield; Feng Gao; Jianwen Dong; Huei-Ping Tzeng; Natarajan Sivasubramanian; Philip M Barger; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2013-03-14       Impact factor: 8.790

10.  Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.

Authors:  A Sigurdsson; O Amtorp; T Gundersen; B Nilsson; J Remes; K Swedberg
Journal:  Br Heart J       Date:  1994-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.